文献速递流行病学与生物统计组学、生物样本库与精准医学

循环维生素D浓度与七种癌症风险:孟德尔随机化研究

Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
PubMed 文献 · BMJ · 2017-10-31

该孟德尔随机化研究利用四个与维生素D相关的单核苷酸多态性构建25(OH)D多基因评分,纳入70 563例癌症病例和84 418例对照,评估循环维生素D浓度与七种癌症风险的因果关联。结果显示,几乎没有证据表明遗传决定的25(OH)D浓度与这七种癌症或其亚型风险相关;作者认为目前不应将人群维生素D缺乏筛查和广泛补充推荐为癌症一级预防策略。

要点

  • 遗传决定的25(OH)D每升高25 nmol/L,结直肠癌OR 0.92(95%CI 0.76–1.10)、乳腺癌OR 1.05(0.89–1.24)、前列腺癌OR 0.89(0.77–1.02)、肺癌OR 1.03(0.87–1.23)。
  • 几乎没有证据支持循环维生素D浓度与七种癌症或其亚型风险存在线性因果关联。
  • 目前不应将人群维生素D缺乏筛查及广泛补充推荐为癌症一级预防策略。

核心结论

  • 几乎没有证据表明循环维生素D浓度与多种类型癌症风险存在线性因果关联,但不能排除低幅度、有临床意义的因果效应存在。
  • 结合既往文献,目前不应将人群维生素D缺乏筛查及后续广泛维生素D补充推荐为癌症一级预防策略。

研究设计与样本

  • 孟德尔随机化研究,数据来自GAME-ON、GECCO、PRACTICAL联盟及MR-Base平台。
  • 纳入70 563例癌症病例(前列腺癌22 898、乳腺癌15 748、肺癌12 537、结直肠癌11 488、卵巢癌4369、胰腺癌1896、神经母细胞瘤1627)和84 418例对照。
  • 采用rs2282679、rs10741657、rs12785878和rs6013897四个与维生素D相关的单核苷酸多态性构建循环25(OH)D多基因评分。

主要发现

  • 遗传决定的25(OH)D每升高25 nmol/L,结直肠癌OR 0.92(95%CI 0.76–1.10)、乳腺癌OR 1.05(0.89–1.24)、前列腺癌OR 0.89(0.77–1.02)、肺癌OR 1.03(0.87–1.23)。
  • 几乎没有证据表明25(OH)D多基因评分与七种癌症或其亚型风险相关。
  • 两种不同分析方法结果一致,研究对中等效应量(如多数主要癌症结局每降低25 nmol/L 25(OH)D对应1.20–1.50)有检验效能。
  • 孟德尔随机化假设似乎未被违反。

关键数值与推荐

  • 结直肠癌:每升高25 nmol/L遗传决定25(OH)D的OR 0.92(95%CI 0.76–1.10)。
  • 乳腺癌:每升高25 nmol/L遗传决定25(OH)D的OR 1.05(95%CI 0.89–1.24)。
  • 前列腺癌:每升高25 nmol/L遗传决定25(OH)D的OR 0.89(95%CI 0.77–1.02)。
  • 肺癌:每升高25 nmol/L遗传决定25(OH)D的OR 1.03(95%CI 0.87–1.23)。

临床怎么用

  • 结果提示循环维生素D浓度与七种癌症风险可能不存在线性因果关联,不能排除低幅度临床相关效应。
  • 这些结果结合既往文献,不支持目前将人群维生素D缺乏筛查及广泛补充作为癌症一级预防策略。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective To determine if circulating concentrations of vitamin D are causally associated with risk of cancer.Design Mendelian randomisation study.Setting Large genetic epidemiology networks (the Genetic Associations and Mechanisms in Oncology (GAME-ON), the Genetic and Epidemiology of Colorectal Cancer Consortium (GECCO), and the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortiums, and the MR-Base platform).Participants 70 563 cases of cancer (22 898 prostate cancer, 15 748 breast cancer, 12 537 lung cancer, 11 488 colorectal cancer, 4369 ovarian cancer, 1896 pancreatic cancer, and 1627 neuroblastoma) and 84 418 controls.Exposures Four single nucleotide polymorphisms (rs2282679, rs10741657, rs12785878 and rs6013897) associated with vitamin D were used to define a multi-polymorphism score for circulating 25-hydroxyvitamin D (25(OH)D) concentrations.Main outcomes measures The primary outcomes were the risk of incident colorectal, breast, prostate, ovarian, lung, and pancreatic cancer and neuroblastoma, which was evaluated with an inverse variance weighted average of the associations with specific polymorphisms and a likelihood based approach. Secondary outcomes based on cancer subtypes by sex, anatomic location, stage, and histology were also examined.Results There was little evidence that the multi-polymorphism score of 25(OH)D was associated with risk of any of the seven cancers or their subtypes. Specifically, the odds ratios per 25 nmol/L increase in genetically determined 25(OH)D concentrations were 0.92 (95% confidence interval 0.76 to 1.10) for colorectal cancer, 1.05 (0.89 to 1.24) for breast cancer, 0.89 (0.77 to 1.02) for prostate cancer, and 1.03 (0.87 to 1.23) for lung cancer. The results were consistent with the two different analytical approaches, and the study was powered to detect relative effect sizes of moderate magnitude (for example, 1.20-1.50 per 25 nmol/L decrease in 25(OH)D for most primary cancer outcomes. The Mendelian randomisation assumptions did not seem to be violated.Conclusions There is little evidence for a linear causal association between circulating vitamin D concentration and risk of various types of cancer, though the existence of causal clinically relevant effects of low magnitude cannot be ruled out. These results, in combination with previous literature, provide evidence that population-wide screening for vitamin D deficiency and subsequent widespread vitamin D supplementation should not currently be recommended as a strategy for primary cancer prevention.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Dimitrakopoulou VI, Tsilidis KK, Haycock PC, et al. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study. BMJ. 2017. PMID: 29089348. doi:10.1136/bmj.j4761

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。